Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+1.58% - - 52.02M
-1.16%+3.41%+8.92%+30.57% 48.01B
+2.67%+2.07%+51.74%+38.37% 45.27B
-1.38%+1.84%+9.13%+88.88% 40.93B
+4.78%+1.48%+359.03%+566.20% 42.84B
-0.62%-1.61%+5.30%+46.02% 29.6B
+0.56%+0.88%+24.79%+155.71% 17.32B
-0.49%+1.18%+26.75%+41.29% 15.34B
+3.39%-3.49% - - 15.15B
+7.38%+2.34%+3.80% - 14.84B
Average +0.84%+1.02%+61.18%+138.15% 29.92B
Weighted average by Cap. +0.95%+1.56%+77.03%+149.56%
Logo Genkyotex SA.
GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.
Employees
9
  1. Stock Market
  2. Stocks
  3. GKTX Stock